RSS   Newsletter   Contact   Advertise with us
Post Online Media

InMed adds William J. Garner to its board of directors

William J. GarnerInMed Pharmaceuticals Inc., a biopharmaceutical company, announces the addition of William J. Garner to the board of directors.
Article continues below

READ MORE InMed appoints Andrew Hull to board

Dr. Garner is the founder of EGB Advisors PR LLC, a pharmaceutical commercialization boutique, where he has focused on advancing technologies and companies to significant value inflection points, leading to monetization of assets via licensing, M&A or IPO transactions.

Dr. Garner has extensive director-level and executive management experience, including his current appointment as Chairman & Founder of Update Pharma and as a Director at IGXBio; previously serving as CEO of Invion Limited, a clinical-stage anti-inflammatory drug development company that resulted from the merger of a private company he founded; and as a co-founder and Director of Del Mar Pharmaceuticals.

Dr. Garner brings additional medical affairs experience from his tenure at Hoffmann LaRoche's oncology division.

Prior to Roche, Dr. Garner was a healthcare merchant banker in New York City.

He has a Master of Public Health from Harvard and earned his M.D. at New York Medical College. Dr. Garner did residency training in Anatomic Pathology at Columbia-Presbyterian and is currently a licensed physician in the State of New York.

InMed also announces it has accepted the resignation of Steve Tong as a Director of the Company.

 LATEST MOVES FROM British Columbia 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy